2020年《欧洲临床营养和代谢学会急慢性胰腺炎临床营养指南》解读

2020-11-20 中国实用外科杂志.2020.40(11):1259-1262.

2020 年1 月欧洲临床营养和代谢学会(ESPEN)发布了最新的急慢性胰腺炎临床营养指南。这是在2002 年急性胰腺炎的临床营养指南、2006年慢性胰腺炎的肠内营养指南、2009 年胰腺胃肠外营养指

中文标题:

2020年《欧洲临床营养和代谢学会急慢性胰腺炎临床营养指南》解读

发布机构:

发布日期:

2020-11-20

简要介绍:

2020 年1 月欧洲临床营养和代谢学会(ESPEN)发布了最新的急慢性胰腺炎临床营养指南。这是在2002 年急性胰腺炎的临床营养指南、2006年慢性胰腺炎的肠内营养指南、2009 年胰腺胃肠外营养指南的基础上,进行高度总结发布的最新的急慢性胰腺炎临床营养指南。改版指南针对急慢性胰腺炎的31 个关键问题提出了42 条共识性建议和7 个声明,主要涉及急慢性胰腺炎的临床营养风险评估、营养干预时机、干预途径、干预类型等治疗过程中的关键问题。较全面地总结和概括了最新的急慢性胰腺炎的临床营养诊治原则和诊疗措施,为急慢性胰腺炎的临床营养诊疗提供了更全面的指导。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020年_欧洲临床营养和代谢学会急慢性胰腺炎临床营养指南_解读_朱桂英.pdf)] GetToolGuiderByIdResponse(projectId=1, id=43dbf1c00201908d, title=2020年《欧洲临床营养和代谢学会急慢性胰腺炎临床营养指南》解读, enTitle=, guiderFrom=中国实用外科杂志.2020.40(11):1259-1262., authorId=0, author=, summary=2020 年1 月欧洲临床营养和代谢学会(ESPEN)发布了最新的急慢性胰腺炎临床营养指南。这是在2002 年急性胰腺炎的临床营养指南、2006年慢性胰腺炎的肠内营养指南、2009 年胰腺胃肠外营养指, cover=https://img.medsci.cn/2020121/1606753102729_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Nov 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #333333;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020 年1 月欧洲临床营养和代谢学会(ESPEN)发布了最新的急慢性胰腺炎临床营养指南。这是在2002 年急性胰腺炎的临床营养指南、2006年慢性胰腺炎的肠内营养指南、2009 年胰腺胃肠外营养指南的基础上,进行高度总结发布的最新的急慢性胰腺炎临床营养指南。改版指南针对急慢性胰腺炎的31 个关键问题提出了42 条共识性建议和7 个声明,主要涉及急慢性胰腺炎的临床营养风险评估、营养干预时机、干预途径、干预类型等治疗过程中的关键问题。较全面地总结和概括了最新的急慢性胰腺炎的临床营养诊治原则和诊疗措施,为急慢性胰腺炎的临床营养诊疗提供了更全面的指导。</p> </div> </div> </div>, tagList=[TagDto(tagId=1021, tagName=胰腺炎)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1021, guiderKeyword=胰腺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3016, appHits=319, showAppHits=0, pcHits=698, showPcHits=2697, likes=4, shares=40, comments=26, approvalStatus=1, publishedTime=Sun Nov 29 00:34:04 CST 2020, publishedTimeString=2020-11-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 30 23:48:18 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 12:13:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020年_欧洲临床营养和代谢学会急慢性胰腺炎临床营养指南_解读_朱桂英.pdf)])
2020年_欧洲临床营养和代谢学会急慢性胰腺炎临床营养指南_解读_朱桂英.pdf
下载请点击:
评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1073485, encodeId=415610e348539, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b95722757, createdName=ms8000001641625967, createdTime=Wed Nov 24 11:03:55 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064937, encodeId=e443106493e2d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/5708c28ded2c4f639b4ade4f8443123c/cea423fee0634769be24503030fc0751.jpg, createdBy=79262456685, createdName=1240a8d9m86暂无昵称, createdTime=Fri Oct 29 11:22:57 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064640, encodeId=4fdd10646404d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:48:36 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064639, encodeId=7a0f106463988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:47:46 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011309, encodeId=2f9010113099b, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb602083980, createdName=1311f2cb65m, createdTime=Wed Aug 25 12:06:45 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-11-24 ms8000001641625967

    真不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1073485, encodeId=415610e348539, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b95722757, createdName=ms8000001641625967, createdTime=Wed Nov 24 11:03:55 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064937, encodeId=e443106493e2d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/5708c28ded2c4f639b4ade4f8443123c/cea423fee0634769be24503030fc0751.jpg, createdBy=79262456685, createdName=1240a8d9m86暂无昵称, createdTime=Fri Oct 29 11:22:57 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064640, encodeId=4fdd10646404d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:48:36 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064639, encodeId=7a0f106463988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:47:46 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011309, encodeId=2f9010113099b, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb602083980, createdName=1311f2cb65m, createdTime=Wed Aug 25 12:06:45 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-10-29 1240a8d9m86暂无昵称

    实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1073485, encodeId=415610e348539, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b95722757, createdName=ms8000001641625967, createdTime=Wed Nov 24 11:03:55 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064937, encodeId=e443106493e2d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/5708c28ded2c4f639b4ade4f8443123c/cea423fee0634769be24503030fc0751.jpg, createdBy=79262456685, createdName=1240a8d9m86暂无昵称, createdTime=Fri Oct 29 11:22:57 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064640, encodeId=4fdd10646404d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:48:36 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064639, encodeId=7a0f106463988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:47:46 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011309, encodeId=2f9010113099b, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb602083980, createdName=1311f2cb65m, createdTime=Wed Aug 25 12:06:45 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-10-28 1debd7bdm05(暂无匿称)

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1073485, encodeId=415610e348539, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b95722757, createdName=ms8000001641625967, createdTime=Wed Nov 24 11:03:55 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064937, encodeId=e443106493e2d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/5708c28ded2c4f639b4ade4f8443123c/cea423fee0634769be24503030fc0751.jpg, createdBy=79262456685, createdName=1240a8d9m86暂无昵称, createdTime=Fri Oct 29 11:22:57 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064640, encodeId=4fdd10646404d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:48:36 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064639, encodeId=7a0f106463988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:47:46 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011309, encodeId=2f9010113099b, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb602083980, createdName=1311f2cb65m, createdTime=Wed Aug 25 12:06:45 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-10-28 1debd7bdm05(暂无匿称)

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1073485, encodeId=415610e348539, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b95722757, createdName=ms8000001641625967, createdTime=Wed Nov 24 11:03:55 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064937, encodeId=e443106493e2d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/5708c28ded2c4f639b4ade4f8443123c/cea423fee0634769be24503030fc0751.jpg, createdBy=79262456685, createdName=1240a8d9m86暂无昵称, createdTime=Fri Oct 29 11:22:57 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064640, encodeId=4fdd10646404d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:48:36 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064639, encodeId=7a0f106463988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd991718374, createdName=1debd7bdm05(暂无匿称), createdTime=Thu Oct 28 10:47:46 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011309, encodeId=2f9010113099b, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb602083980, createdName=1311f2cb65m, createdTime=Wed Aug 25 12:06:45 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-08-25 1311f2cb65m

    真不错

    0

拓展阅读

2010 ACR准则:急性胰腺炎

美国放射学会(ACR,American College of Radiology) · 2010-01-01

2010 ERCP指南:ERCP术后胰腺炎的预防

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2010-03-01

2011 IAP指南:自身免疫性胰腺炎的诊断标准

国际胰腺病协会(IAP,International Association of Pancreatology) · 2011-04-01

2011 SEMICYUC-SENPE共识 重症患者营养与代谢专业支持指导指南(第七章):重症急性胰腺炎

西班牙肠外肠内营养学会(SENPE,Spanish Society of Parenteral and Enteral Nutrition) · 2011-11-01

2012 胰腺炎营养治疗国际共识指南

美国肠外肠内营养学会(ASPEN,American Society for Parenteral and Enteral Nutrition) · 2012-04-24

慢性胰腺炎诊治指南(2012,上海)

中华胰腺病杂志编委会 · 2012-06-01